ROZANOLIXIZUMAB
Rozanolixizumab 280 mg/2 mL injection, 2 mL vial
ROZANOLIXIZUMAB (15398K)
15398K
Manner of administration:Injection
Restriction
Indication: Acute severe generalised myasthenia gravis (gMG)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 18 | Max qty units: 18 | # of repeats: 1 | DPMQ: $219,189.60 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Rystiggo | |||||